Pfizer acquires Angiosyn, a biopharmaceutical company
Client(s) Pfizer, Inc.
Jones Day acted as principal outside tax counsel to Pfizer in its agreed acquisition of Angiosyn, a biopharmaceutical company focused on the discovery and development of technology to ward off blindness.